Biosimilar Filgrastim vs Lenograstim in Autologous HSCTBiosimilar Filgrastim vs Lenograstim in Autologous HSCT

Find out how these biosimilars stack up for autologous HSCT in patients with hematological malignancies. Therapeutic Advances in Hematology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news